Because the integrin α5β1 inhibitor ATN-161 can inhibit angiogenesis,35, 36 we never exclude the possibility that ATN-161 administration might decrease the tumour growth of MDA-MB-231 cells and WT MEFs by inhibiting both L1CAM-mediated proliferation and angiogenesis. Here, L1CAM is linked to neoplasm.